Evidence map›Paper›PMID 38673592›Full record

ArticleJournal of clinical medicine2024

Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments.

Tatjana Welzel, Beate Zapf, Jens Klotsche, Özlem Satirer, Susanne M Benseler, Jasmin B Kuemmerle-Deschner

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. When should a neonatologist consult a rheumatologist?European journal of pediatrics · 2025
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Tatjana WelzelPediatric Rheumatology, University Children's Hospital Basel, University of Basel, 4031 Basel, Switzerland.ORCID 0000-0003-1800-0327
Beate ZapfDivision of Pediatric Rheumatology, Department of Pediatrics, autoinflammatory reference centre Tuebingen, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Jens KlotscheGerman Rheumatism Research Centre Berlin, 10117 Berlin, Germany.ORCID 0000-0002-2954-5755
Özlem SatirerDivision of Pediatric Rheumatology, Department of Pediatrics, autoinflammatory reference centre Tuebingen, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Susanne M BenselerPediatric Rheumatology, Department of Paediatrics, Alberta Children's Hospital, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Jasmin B Kuemmerle-DeschnerDivision of Pediatric Rheumatology, Department of Pediatrics, autoinflammatory reference centre Tuebingen, University Hospital Tuebingen, 72076 Tuebingen, Germany.
German Rheumatism Research Centre · DEUniversity of Basel · CHUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

autoinflammatory diseaseCAPSeffectivenessexposure–responseFMFmonitoringoutcomepersonalized medicineremissionTRAPS

Identifiers

PMID38673592
PMCPMC11050771
OpenAlexW4394878994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.